International: Capivasertib, a breakthrough drug for advanced HR-positive HER2-negative breast cancer, has been approved by ...

Today, we've recommended capivasertib (also called Truqap and made by AstraZeneca) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer ...

Capivasertib is taken as a twice-daily pill, in combination with the hormone therapy fulvestrant. The drug works by blocking ...

Katie Thurston no longer needs chemotherapy after getting a second opinion about her breast cancer. The 'Bachelorette' star ...

Bachelorette’ star Katie Thurston revealed that her breast cancer diagnosis has changed after seeking a second opinion. The 34-year-old’s treatment plan now no longer includes chemotherapy.

Katie Thurston, bold and charismatic woman who captured hearts as The Bachelorette, is currently facing a challenging period ...

Katie Thurston's breast cancer fight has taken a surprising twist. She took to Instagram on Thursday to reveal that her ...

Relay Therapeutics gains capital via licensing, reduces costs, and advances its promising PI3K-alpha inhibitor. See why RLAY ...

When Dr. Darshan Shah was 42 and expecting his first child, he realized it was time to improve his health. He made changes ...

More and more women are turning away from the pill, as worries grow around side-effects, stoked by misinformation on social ...

There will be about 299,010 new cases of prostate cancer diagnosed this year, according to the American Cancer Society.